When your blood becomes too thick: understanding the risks of erythrocytosis

When your blood becomes too thick: understanding the risks of erythrocytosis
Image: Intellect (generated)

In short: Erythrocytosis occurs when your blood contains an abnormally high concentration of red blood cells. This thickening makes blood flow sluggish, potentially leading to serious complications like blood clots, heart attacks, or strokes. While some cases are mild, others signal underlying health issues or rare blood cancers requiring medical intervention.

Erythrocytosis is defined by elevated levels of hematocrit—the space red blood cells occupy in the blood—and hemoglobin. The condition is broadly categorized into two types: relative and absolute. Relative erythrocytosis is not a true increase in cell production but a decrease in plasma volume, often caused by dehydration, smoking, or obesity. In contrast, absolute erythrocytosis involves the actual overproduction of red blood cells, which can be primary or secondary in origin.

Primary erythrocytosis, most commonly represented by the rare blood cancer polycythaemia vera, stems from bone marrow dysfunction. Often linked to a mutation in the JAK2 gene, this condition causes marrow to produce excessive red blood cells, platelets, and white blood cells. While it is a genetic change, it is typically acquired later in life rather than inherited, with an average diagnosis age of 60. Secondary erythrocytosis occurs when external factors, such as chronic obstructive pulmonary disease or kidney issues, trigger the kidneys to overproduce erythropoietin, the hormone that stimulates red cell creation.

Symptoms vary widely and can include headaches, dizziness, blurred vision, and itchy skin, particularly after a warm bath. Because thickened blood increases the risk of life-threatening clots, such as deep vein thrombosis or pulmonary embolisms, diagnosis is critical. Doctors use blood tests to assess cell counts and may perform ultrasound scans or genetic testing to identify the cause. Treatment focuses on reducing blood viscosity, often through venesection—the removal of blood—or medications like hydroxycarbamide or interferon to regulate cell production and prevent long-term complications.

The clinical threshold for diagnosis depends on individual factors like age and sex. For instance, in men, hematocrit levels above 50% may indicate the condition, while for non-pregnant women, the threshold is above 45%. Because many people remain asymptomatic, the condition is frequently discovered during routine testing for unrelated health concerns, highlighting the importance of monitoring blood health.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-polycythemia.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…